文献速递病毒性肝炎

白细胞介素21增强慢性乙肝患者HBV特异性CD8+ T细胞的抗病毒活性

Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection.
PubMed 文献 · J Infect Dis · 2019-01-01

该研究通过慢性HBV感染者样本和HBV表达小鼠模型,发现IL-21可促进HBV特异性CD8+ T细胞增殖、下调抑制性受体PD-1和Tim-3、增强干扰素-γ和颗粒酶B及CD107a产生,并增强对HepG2.2.15细胞的杀伤。IL-21受体敲除小鼠HBV特异性CD8+ T细胞频率降低、血清HBsAg升高,而给予重组IL-21可增强CD8+ T细胞功能并加速HBsAg清除。提示IL-21可能有助于慢性HBV感染病毒清除。

要点

  • IL-21增强慢性HBV感染中HBV特异性CD8+ T细胞增殖和抗病毒功能。
  • IL-21下调PD-1和Tim-3,提升干扰素-γ、颗粒酶B和CD107a。
  • IL-21受体敲除加重小鼠HBV抗原血症,重组IL-21加速HBsAg清除。

核心结论

  • IL-21增强HBV特异性CD8+ T细胞的抗病毒效应,可能促进慢性HBV感染的病毒清除。

研究设计与样本

  • 研究分析慢性HBV感染者样本和HBV表达小鼠模型,包括IL-21受体敲除小鼠和野生型小鼠给予重组小鼠IL-21。

主要发现

  • IL-21促进HBV特异性CD8+ T细胞增殖并下调PD-1和Tim-3表达。
  • IL-21增加HBV特异性CD8+ T细胞产生干扰素-γ、颗粒酶B和CD107a,并增强对HepG2.2.15细胞的杀伤活性。
  • IL-21受体敲除的HBV小鼠模型HBV特异性CD8+ T细胞频率显著降低、血清HBsAg水平升高。
  • 野生型HBV小鼠模型给予重组小鼠IL-21后HBV特异性CD8+ T细胞功能增强、HBsAg清除加速。

临床怎么用

  • IL-21通路可能是慢性HBV感染免疫治疗中恢复CD8+ T细胞功能的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Strategies that target functional recovery of exhausted hepatitis B virus (HBV)-specific CD8+ T cells are beneficial for viral control, but the potential for interleukin 21 (IL-21) to rescue CD8+ T-cell function is not well understood. METHODS: We investigated the effect of IL-21 on CD8+ T-cell responses by phenotypic and functional analysis of samples from patients with chronic HBV infection and a mouse model with HBV expression. RESULTS: IL-21 promoted the proliferative capacity of HBV-specific CD8+ T cells and down-regulated expression of the inhibitory receptors programmed death 1 and T-cell immunoglobulin domain and mucin domain 3. Additionally, IL-21 boosted the production of interferon-γ, granzyme B, and CD107a in HBV-specific CD8+ T cells and enhanced the cytolytic activity of CD8+ T cells against HepG2.2.15 cells. Notably, an HBV mouse model established from IL-21 receptor knockout mice showed significantly decreased frequency of HBV-specific CD8+ T cells and increased levels of serum hepatitis B surface antigen (HBsAg). Meanwhile, administration of recombinant mouse IL-21 in an HBV mouse model established from wild-type mice resulted in enhanced functionality of HBV-specific CD8+ T cells and accelerated HBsAg clearance. CONCLUSIONS: IL-21 enhances the antiviral effect of HBV-specific CD8+ T cells, suggesting that it may contribute to viral clearance in chronic HBV infection.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tang L, Chen C, Gao X, et al. Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection. J Infect Dis. 2019. PMID: 30260401. doi:10.1093/infdis/jiy576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。